Impact of Pharmaceutical Services on Elderly Prostate Cancer: Drug-Related Problems, Disease Knowledge, Health-Related Quality of Life, and Satisfaction.
Xiaohua Zhang, Shaofeng Shao, Chongfeng Lin, Lin Hong
{"title":"Impact of Pharmaceutical Services on Elderly Prostate Cancer: Drug-Related Problems, Disease Knowledge, Health-Related Quality of Life, and Satisfaction.","authors":"Xiaohua Zhang, Shaofeng Shao, Chongfeng Lin, Lin Hong","doi":"10.56434/j.arch.esp.urol.20257803.44","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Drug-related problems (DRPs) are prevalent among older cancer patients. This study aimed to investigate the impact of pharmaceutical services on DRP, disease knowledge, health-related quality of life, and satisfaction among older patients with prostate cancer (PCa).</p><p><strong>Methods: </strong>The clinical data of 86 elderly patients with PCa admitted during June 2021-June 2024 were retrospectively analyzed. Descriptive statistics and univariate analysis were used to evaluate the effectiveness of the clinical application of the pharmacy service carried out in our hospital, including the incidence of DRP, knowledge of disease, health-related quality of life score, and satisfaction. The general content of pharmaceutical services is as follows: Arrange hospital pharmacists to directly participate in patient treatment, conduct drug reviews, identify DRPs, and discuss with prescribing doctors based on problems to optimize medication plans. At the same time, it provides disease knowledge education, medication consultation, and primary care guidance.</p><p><strong>Results: </strong>At admission, 55 patients (63.95%) had DRP, with the most common classification being drug selection, with an incidence rate of 36.36% (20/55). At discharge, the proportion of DRP in patients receiving pharmaceutical services was lower than that in patients refusing pharmaceutical services, and the DRP status was better than that of patients refusing pharmaceutical services (<i>p</i> < 0.05). Patients who received pharmaceutical services had higher level of disease knowledge mastery (<i>p</i> < 0.001), Short-Form-36 (SF-36) score in some dimensions (<i>p</i> < 0.05), and satisfaction (<i>p</i> < 0.05) than those who refused pharmaceutical services.</p><p><strong>Conclusions: </strong>Hospital pharmaceutical services can effectively reduce the occurrence of DRP during hospitalization of elderly patients with PCa, help them to acquire knowledge of the disease and health-related quality of life, and have high patient satisfaction.</p>","PeriodicalId":48852,"journal":{"name":"Archivos Espanoles De Urologia","volume":"78 3","pages":"325-333"},"PeriodicalIF":0.6000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos Espanoles De Urologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.56434/j.arch.esp.urol.20257803.44","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Drug-related problems (DRPs) are prevalent among older cancer patients. This study aimed to investigate the impact of pharmaceutical services on DRP, disease knowledge, health-related quality of life, and satisfaction among older patients with prostate cancer (PCa).
Methods: The clinical data of 86 elderly patients with PCa admitted during June 2021-June 2024 were retrospectively analyzed. Descriptive statistics and univariate analysis were used to evaluate the effectiveness of the clinical application of the pharmacy service carried out in our hospital, including the incidence of DRP, knowledge of disease, health-related quality of life score, and satisfaction. The general content of pharmaceutical services is as follows: Arrange hospital pharmacists to directly participate in patient treatment, conduct drug reviews, identify DRPs, and discuss with prescribing doctors based on problems to optimize medication plans. At the same time, it provides disease knowledge education, medication consultation, and primary care guidance.
Results: At admission, 55 patients (63.95%) had DRP, with the most common classification being drug selection, with an incidence rate of 36.36% (20/55). At discharge, the proportion of DRP in patients receiving pharmaceutical services was lower than that in patients refusing pharmaceutical services, and the DRP status was better than that of patients refusing pharmaceutical services (p < 0.05). Patients who received pharmaceutical services had higher level of disease knowledge mastery (p < 0.001), Short-Form-36 (SF-36) score in some dimensions (p < 0.05), and satisfaction (p < 0.05) than those who refused pharmaceutical services.
Conclusions: Hospital pharmaceutical services can effectively reduce the occurrence of DRP during hospitalization of elderly patients with PCa, help them to acquire knowledge of the disease and health-related quality of life, and have high patient satisfaction.
期刊介绍：
Archivos Españoles de Urología published since 1944, is an international peer review, susbscription Journal on Urology with original and review articles on different subjets in Urology: oncology, endourology, laparoscopic, andrology, lithiasis, pediatrics , urodynamics,... Case Report are also admitted.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
